These engineered cellular models assess T cell activation through key signaling pathways. NFAT and NFκB reporter lines measure early transcriptional activity, while IL-2 secretion assays quantify functional cytokine output. Ideal for screening immunomodulators, bispecific antibodies, and CAR-T candidates, they deliver reliable, quantitative data for immunotherapy development.
